Followers | 829 |
Posts | 119686 |
Boards Moderated | 16 |
Alias Born | 09/05/2002 |
Tuesday, May 07, 2024 5:41:52 PM
https://www.globenewswire.com/news-release/2024/05/07/2877224/0/en/Aligos-Therapeutics-Reports-Recent-Business-Progress-and-First-Quarter-2024-Financial-Results.html
Cash at 3/31/24 was $112.7M, down from $135.7M at 12/31/23.
No details on when a phase-2 COVID trial, with support from NIH, will start. The PR merely says, “phase-2 enabling activities…are underway.”
No CC.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ALGS News
- Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024 • GlobeNewswire Inc. • 05/22/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:02:52 PM
- Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 09:01:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:05:32 PM
- Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
- Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024 • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024 • GlobeNewswire Inc. • 03/05/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:44:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:42:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:35:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:33:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:31:16 PM
- Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024 • GlobeNewswire Inc. • 02/20/2024 01:00:00 PM
- Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments • GlobeNewswire Inc. • 02/13/2024 01:00:00 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 01/30/2024 12:04:23 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM